Background: Carcinoma in parathyroid is diagnosed when there is recurrence or metastasis or fulfillment of histological criteria. Immunohistochemical (IHC) markers are used to assist in difficult cases. Associations of IHC markers with unfavorable clinical or histological features that predict aggressive behavior of parathyroid neoplasms have not been reported so far. We planned to study the direct association of IHC markers with biochemical and histological features in parathyroid neoplasms. Materials and methods: IHC for parafibromin (PF), adenosis polyposis coli (APC), galectin-3 (Gal-3), and PGP9.5 was performed and correlated with biochemical and histological features. Result: PF loss, Gal-3, and PGP9.5 overexpression alone or in combination showed significant association with one or more features like hypercalcemic crisis; low serum vitamin D; raised serum alkaline phosphatase (ALP); diffuse sheet pattern; predominant oncocytic histology; diffuse macronucleoli; thick fibrous bands; and capsular, vascular, and adjacent tissue invasion. The majority of histological features that significantly correlated with the expression or loss of IHC makers is included in the current criteria for diagnosing malignancy in parathyroid neoplasms.
IntroductIon
Parathyroid carcinoma is a rare neoplasm accounting for 0.1-5% of all parathyroid neoplasms in patients with primar y hyperparathyroidism and shows higher frequency in Asians than in Westerners. [1] [2] [3] [4] [5] [6] The clinical signs and symptoms of benign and malignant parathyroid lesions show a significant overlap in the form of marked hypercalcemia and high serum parathyroid hormone levels, and definitive diagnosis of malignancy is based on histological criteria. Absolute diagnosis of parathyroid carcinoma requires documentation of distant or lymph node metastasis; however, malignant potential in parathyroid neoplasms can be predicted based on certain histological features in postoperative specimens as given by Bondeson and Chan et al. Some of these features in the histological criteria are considered absolute for diagnosing carcinoma where even one feature is sufficient to label a parathyroid neoplasm as carcinoma whereas others are minor features where a minimum number of four features are required to predict malignancy. 1, [7] [8] [9] There is evidence that though certain histological features have been used to predict malignant behavior in parathyroid neoplasms, these features have not shown consistency with the aggressive biological behavior of malignant neoplasms, as a proportion of histologically benign parathyroid tumors show recurrence or metastasis and histologically malignant tumors behave in a benign fashion without long-term recurrence or metastasis.
stage, and lymphovascular invasion in breast, colorectal, and gastric cancers. [18] [19] [20] [21] Gal-3 is the only member of the galectin family having an antiapoptotic effect which has a role in several biological functions including tumor cell adhesion, proliferation, differentiation, angiogenesis, cancer progression, and metastasis. It is expressed in thyroid, colorectal, breast, gastric, and liver cancers; brain tumors; large cell lymphoma; and melanoma. [19] [20] [21] [22] [23] [24] PGP9.5 is a neuron-specific protein, having opposing biological functions, acting both as ubiquitin carboxyl-terminal hydrolase and ligase. It was normally thought to be expressed in neuroendocrine and neural cells; however, it has been expressed in a variety of other normal tissues including mammary epithelial cells, melanocytes, distal renal tubular epithelium, fibroblasts, and germ cells. PGP9.5 has been associated with the progression of the disease stage in lung, colorectal, pancreatic, and mesenchymal tumors. [25] [26] [27] [28] [29] Tokumaru et al. showed that inactivation of PGP9.5 via promoter hypermethylation or gene deletion was significantly related to head and neck squamous cell carcinoma and pancreatic carcinoma, suggesting its tumor suppressor action. 25 Its overexpression is known to be strongly associated with parathyroid carcinoma and HPT-JT-related tumors. 12 The sensitivity and specificity of PF, Gal-3, APC, and PGP9.5 for parathyroid carcinoma have been reported to be high, though it is variable in different studies. 12, 13, 19, 22, [30] [31] [32] [33] [34] [35] [36] [37] The fact is that the sensitivity and specificity of these IHC markers in parathyroid neoplasms have been assessed with respect to the histological criteria [1] [2] [3] [4] [5] [6] [7] 9 for diagnosing benign and malignant tumors which itself does not accurately predict the biological behavior of parathyroid carcinoma. 10, 11 Whether these IHC markers have any direct association with worrisome histological feature required for diagnosing malignancy is not clearly known, neither has it been well evaluated. Therefore, this study was planned to find out if there is any direct association of PF loss or overexpression of Gal-3 and PGP9.5 with the individual biochemical and histological features in parathyroid neoplasms and whether any feature can independently predict the expression of an individual or a combination of IHC markers.
MAterIAls A n d Methods
All consecutive parathyroidectomy specimens received in the Department of Pathology at a tertiary care referral center from January 1993 to December 2013 within a period of 21 years were retrieved and clinical, biochemical, and gross findings were recorded from hospital records and case files. All cases were reviewed histologically according to the criteria given by Chan et al. and DeLellis et al. as shown in Table 1 . 1, [7] [8] [9] The cases were categorized into five diagnostic categories-carcinoma, atypical adenoma, adenoma including lipoadenoma, double adenoma, and hyperplasia. The diagnosis of carcinoma or atypical adenoma was done according to the criteria mentioned in Table 1 . High serum calcium was defined as the serum calcium level >11 g/dL (normal range: 9-11 mg/dL) and hypercalcemic crisis as the serum calcium level >14 g/dL. Hypophosphatemia was defined as the serum phosphorus level of <3.0 mg/dL (normal range: 3-5 mg/dL), raised parathormone (PTH) was defined as the serum PTH level of >55 pg/mL (normal range: 9-55 pg/dL), raised alkaline phosphatase (ALP) was defined as the serum ALP levels of >150 IU/L (normal range: 35-150 IU/L), raised creatinine was defined as the serum creatinine level of >1.5 mg/dL (normal range: 0.5-1.5 mg/dL), and low vitamin D levels was defined as the serum vitamin D level of <9.0 ng/mL (normal range: 9-54 ng/dL).
Predominant oncocytic tumors were designated when >75% of tumor cells were oncocytes with large size and granular eosinophilic cytoplasm. This cutoff percentage for predominantly oncocytic tumor was based on previously reported cutoff values for oncocytic histology in thyroid, parathyroid, as well as other neuroendocrine tumors, ranging from 60 to 100%. 38 The subset of oncocytic tumors having >90% oncocytic cells was also analyzed separately. Similarly, a tumor with diffuse macronucleoli was categorized when >75% of tumor cells had prominent nucleolus.
IHC was performed for PF, APC, Gal-3, PGP9.5, and Ki-67. Mouse monoclonal antibodies were used for PF (clone-2H1) and Gal-3 (clone-B2C10) from Santa Cruz at a dilution of 1:20 and 1:50, respectively. Rabbit monoclonal antibody was used for APC (clone-EP701Y, Abcam), whereas rabbit polyclonal antibody was used for PGP9.5 (DAKO) at a dilution of 1:50 each. Ki-67 was used (DAKO, clone-MIB1) at 1:50 dilution. Antigen retrieval for PF, APC, Gal-3, and Ki-67 was done in citrate buffer (pH 6.0) and for PGP9.5 in Tris EDTA (pH 9.0). Primary antibodies were incubated for 1 hour at room temperature followed by secondary antibody (Ultra Vision Quanto Detection System-Thermo Scientific) for 30 minutes. The cutoff for positive expression of different antibodies was based on different studies in the literature. 12, 18, 19 
Interpretation of Immunohistochemistry Results

PF
• The proportion of positive nuclei out of total tumor nuclei was expressed in percentage. The complete loss was defined as <10% nuclear staining of tumor cells. Any staining more than 10% was taken as positive staining. 
8
• The rim of normal parathyroid tissue and stromal fibroblasts within the tumor were taken as positive internal controls.
APC
• Complete loss of APC was defined as <10% cytoplasmic immunostaining of any intensity.
Gal-3 and PGP9.5
• Both cytoplasmic staining and nuclear staining were taken as positive.
• Cases with >50% (PGP9.5) and >30% (Gal-3) moderate to strong immunostaining were considered immunoreactive.
Ki-67
• Ki-67 was counted as the number of consecutive positive nuclei in 1,000 cells manually and categorized into two groups with >5% and <5%. For all antibodies, the intensity was graded as mild, moderate, and severe based on the subjective assessment. IHC results were then correlated with biochemical features, tumor weight, and histological features.
Statistical Analysis
The data were analyzed using statistical package for social sciences (SPSS) software version 20.0. Categorical variables were analyzed by Chi-square (univariate) and binary logistic regression (multivariate) tests. The Fischer exact test was applied to assess the level of significance, wherever the values were 5 or less. A p value of <0.05 was considered as statistically significant.
results
A total of 246 parathyroid resections were received within a period of 21 years. Neoplastic lesions accounted for 227 cases comprising of 194 adenomas including three cases of lipoadenomas, 19 atypical adenomas, and 14 carcinomas. Nineteen cases having involvement of more than one gland (3 cases of double adenoma and 16 cases of hyperplasia) were excluded from the final analysis. Thus, 227 parathyroid neoplasms were included for further workup. Carcinoma showed a higher mean age of 47.4 years (range 30-66 years, median 51.0 years). Atypical adenoma and adenoma had nearly similar age of presentation with a mean of 40.7 years (17-76 years, median 40.0 years) and 41.6 years (12-76 years, median 41.0 years), respectively. The male-to-female ratio was 1.8:1 for carcinoma, 0.9:1 for atypical adenoma, and 0.4:1 for adenoma.
The presenting complaints (bone pain, trivial fractures, recurrent renal stones, pancreatitis, and proximal muscle weakness) and biochemical alterations (raised serum calcium, hypercalcemic crisis, low serum phosphorus, high serum PTH, and low serum vitamin D) were largely similar in all three diagnostic categories. Bony lesions (deformities or cystic tumors) were less in carcinoma than in adenoma and atypical adenoma (p value = 0.005), whereas high serum ALP was more common in carcinoma and atypical adenoma (p value = 0.04).
PF, Gal-3, and PGP9. 5 Univariate analysis showed significant association of PF loss with hypercalcemic crisis (p value 0.005), low serum phosphorus (p value 0.04), and low serum vitamin D (p value 0.04). Loss of APC expression was associated only with proximal muscle weakness (p value = 0.007). Gal-3 overexpression was associated with bony lesions (p value = 0.004) and low serum vitamin D (p value = 0.02). PGP9.5 overexpression was seen with high serum calcium (p value = 0.01), hypercalcemic crisis (p value = 0.001), and raised serum ALP (p value = 0.03). The correlation of individual IHC markers with clinical and biochemical features is shown in Table 2 . In multivariate analysis, the Gal-3 overexpression was independently associated with bony lesions and deformities (p value = 0.001, odds ratio = 7.0, 95% CI = 2.1-22.5), whereas PGP9.5 was associated with hypercalcemic crisis (p value = 0.009, OR = 3.9, 95% CI = 1.4-10.9) and raised ALP (p value = 0.004, odds ratio = 4.0, 95% CI = 1.0-16.4).
The individual histological features of parathyroid neoplasms were also analyzed with loss of PF and APC and overexpression of Gal-3 and PGP9.5. Loss of PF was significantly associated with predominantly nested and sheet-like cellular arrangement, predominantly chief or oncocytic cell morphology at both cutoff values (75% and 90%), high cellularity, thick fibrous bands with the formation of expansile nodules, >5 mitosis/10 HPF, capsular invasion, vascular invasion, and adjacent tissue invasion on univariate analysis; however, on multivariate analysis only association was seen only with capsular invasion (p value = 0.001, odds ratio 21.6, 95% CI-4.8 to 97.7). None of the histological features showed any association with APC loss. Gal-3 overexpression was significantly associated with predominantly sheet-like arrangement, predominantly chief or oncocytic histology at both cutoff values (having either 75% Table 3 .
Coagulative tumor necrosis, a feature associated with malignancy, was present only in two cases of atypical adenoma and one case of carcinoma. One case of carcinoma with necrosis showed PF loss and PGP9.5 overexpression. Two cases of atypical adenoma showed Gal-3 overexpression. These findings were indicative of necrosis being a worrisome feature expressing IHC markers of the malignant phenotype.
The combination of PF loss + Gal-3 overexpression, PF loss + PGP9.5 overexpression, and PF loss + PGP9.5 and Gal-3 overexpression also showed significant association with certain biochemical and histological features as mentioned in Tables 4  and 5 (Fig. 2) . Loss of PF and Gal-3 overexpression was independently associated with hypercalcemic crisis (p value = 0.005, odds ratio = 44.3, 95% CI = 3.1-627.4), predominantly oncocytic histology (p value < 0.001, odds ratio = 42.8, 95% CI = 8.2-221.6), capsular invasion (p value = 0.002, odds ratio = 44.0, 95% CI = 3.9-489.2), and diffuse macronucleoli (p value = 0.04, odds ratio = 91.3, 95% CI = 1.1-7105.8). Loss of PF and PGP9.5 overexpression was independently associated with predominantly oncocytic histology (p value < 0.001, odds ratio = 65.9, 95%, CI = 12.8-338.4) and adjacent tissue invasion (p value = 0.01, odds ratio = 63.1, 95% CI = 2.2-1810.1). Combination of PF loss with Gal-3 and PGP9.5 expression was independently associated with hypercalcemic crisis (p value = 0.007, odds ratio = 35.9, 95% CI = 2.6-495.9), predominantly oncocytic histology (p value < 0.001, odds ratio = 49.0, 95%, CI = 9.2-259.9), and capsular invasion (p value = 0.002, odds ratio = 50.9, 95% CI = 4.0-640.7).
All tumors with predominant oncocytic cell type using >75% as well as >90% cutoff value (n = 30) were correlated with PF and APC loss and Gal-3 and PGP9.5 expression which included 20 adenomas, 3 atypical adenomas, and 7 carcinomas (5 carcinomas had >90% oncocytic cells). The atypical adenoma and carcinoma using >75% cutoff value showed significant association with PF loss (p value = 0.002) or Gal-3 (p value = 0.002) and PGP9.5 expression (p value = 0.02) either individually or in combination (p value = 0.001). A similar association was also noted for carcinomas having >90% oncocytic cells. Among the seven oncocytic parathyroid carcinomas using >75% cutoff criteria, five cases (71%) showed strong expression of both Gal-3 and PGP9.5 and four of these also showed loss of PF. Of the remaining two cases, one showed positive expression of PGP9.5 alone while the other showed loss of both. The oncocytic carcinoma that showed loss of both Gal-3 and PGP9.5 showed retained nuclear expression of PF; however, this tumor was histologically malignant and was composed of >90% oncocytic cells. The remaining four out of five oncocytic carcinomas using >90% cutoff value showed complete PF loss in all cases, positive expression of both Gal-3 and PGP9.5 in three cases and expression of PGP9.5 alone in the remaining one case. Thus, oncocytic histology was associated with the expression of Gal-3 and PGP9.5 alone or in combination in a similar proportion of carcinomas using >75% as well as >90% cutoff criteria.
The Ki-67 index of >5% was significantly associated with thick fibrous bands, severe nuclear atypia, necrosis, capsular invasion, 
dIscussIon
The histological criterion is currently considered as the gold standard for predicting malignant potential in parathyroid tumors; however, malignant parathyroid tumors diagnosed by the histological criteria may behave in a benign fashion. 1, [7] [8] [9] [10] [11] The gray category of atypical adenoma, again based on the histological criteria, adds to the uncertainty. IHC markers have been used in conjunction with histological features to predict malignant behavior of parathyroid neoplasms with more accuracy. The panel of IHC markers studied in parathyroid tumors to differentiate between benign and malignant lesions has been found to be related to malignancy or disease progression in several other cancers. 20, 21, [23] [24] [25] [26] [27] [28] [29] The questions remain that if histology is not accurate and specific to predict the malignant behavior, how can the sensitivity and specificity of these IHC markers be derived taking histology as the gold standard? Therefore, we evaluated the direct association of IHC markers with individual biochemical and histological features. A previous study from the present authors studied the diagnostic categories of parathyroid neoplasms based solely on histological criteria and correlated the IHC markers with the histological categories; however, no recurrence or metastasis was seen in 33 cases of atypical adenoma and carcinoma except for one case of carcinoma in a follow-up period ranging from 1 to 162 months (mean 25 months). 38, 39 Thus, our earlier finding questions the strength of histological criteria being the gold standard.
The sensitivity and specificity of PF loss in parathyroid carcinoma have been reported in the range of 4.5-100% and 89.5-100%, respectively, in different studies. 12, 13, 19, 22, [32] [33] [34] [35] [36] [37] In the present study, sensitivity, specificity, and predictive accuracies of PF loss for carcinoma were 50%, 90.2%, and 87.5%, respectively, which shows that PF is more helpful in excluding malignancy rather than diagnosing malignancy. Reported sensitivity and specificity of Gal-3 expression in parathyroid carcinoma range between 54.2-93.3% and 73.7-100%, respectively. 12, 13, 19, 22, [32] [33] [34] [35] [36] [37] Sensitivity, specificity, and predictive accuracies of Gal-3 in PC in the present study were 45.4%, 90.2%, and 83.7%, respectively, again emphasizing its role in excluding malignancy in parathyroid neoplasms. The reported sensitivity, specificity, and predictive accuracies of PGP9.5 expression in parathyroid carcinoma are 33.3-63.6%, 85-100% and 58.9-92% respectively, in different studies.
12,37 Sensitivity, The numbers are percentages as the total numbers available in each group were variable specificity, and predictive accuracies of PGP9.5 in the present study were 45.4%, 85%, and 79.3%, respectively. We could not find any literature evaluating the direct association of these IHC markers with clinicopathological features in parathyroid neoplasms. In the present study, IHC expression or loss was correlated with clinicopathological features that showed the presence of certain biochemical (hypercalcemic crisis and raised serum ALP) and histological (sheet-like pattern, predominance of oncocytic cell type (using both >75% and >90% cutoff criteria), capsular invasion, and adjacent tissue invasion) features were independently associated with either one or combination of antibodies. The oncocytic histology in four cases of histological adenoma and three cases of atypical adenoma showed complete PF loss and overexpression of Gal-3 and PGP9.5 in 60-100% of tumor cells which again raises concern over their malignant potential. Moreover, it is believed that histologically benign or atypical parathyroid neoplasms with loss of PF should be considered as parathyroid neoplasms of low malignant potential, whereas intact PF staining in malignant parathyroid neoplasms indicates low malignant potential. [39] [40] [41] Some of the previously mentioned features are included in the histological criteria for diagnosing risk of malignancy as given by Chan et al., DeLellis et al., and Bondeson et al., such as capsular, vascular, and adjacent tissue invasion; thick fibrous bands; diffuse macronucleoli and diffuse sheet like pattern; however, clinical or biochemical features are not a part of histological criteria. 1, [7] [8] [9] Observations of the present study indicate that predictive accuracy of the above diagnostic criteria can be enhanced by the inclusion of certain biochemical and histological features like hypercalcemic crisis, and predominant oncocytic cell type, as these features also positively correlate with IHC markers for parathyroid carcinoma. The importance of predominantly oncocytic histology can be affirmed by the fact that 7 of the 14 carcinomas in the present study were composed predominantly of oncocytic histology. This feature was significantly associated with carcinoma and also with Gal-3 and PGP9.5 expression irrespective of histological diagnosis. We tried to find out any difference in the association of these IHC markers between oncocytic adenoma and carcinoma and found that the oncocytic carcinomas showed significant association (p value = 0.002) with all the three markers, both singly and in combination, compared to adenoma. However, the oncocytic histology also showed significant association with PGP9.5 overexpression in adenomas. Published studies have shown that oncocytic tumors tend to be non-functional and, hence, are mostly diagnosed at a later stage with larger tumor size and higher tumor weight. In the present study, four cases of oncocytic parathyroid carcinoma using >75% cutoff were functional with raised PTH levels and hypercalcemic crisis was noted in two of these. In the remaining three cases, PTH levels were not available; however, two of these showed hypercalcemia. The number of oncocytic carcinoma in the present study is too and diffuse sheet like pattern less to derive any statistical significance and more studies with a greater number of cases are required to validate our findings.
Therefore, the basis of histological criteria for predicting the risk of malignancy is still debatable and the only proof of malignancy of histologically and/or immunohistochemically diagnosed parathyroid carcinoma is either metastasis or recurrence. This is also reinforced from findings of the present study where only 1 (7%) of 14 histologically diagnosed parathyroid carcinoma in 21 years showed recurrence and rest showed a benign behavior. The question still remains-What are reliable features (clinical, biochemical, histological, or molecular) that can diagnose a parathyroid neoplasm as malignant which actually behave in a malignant fashion?
conclusIon
The present study showed direct association of worrisome histological features (capsular invasion, adjacent tissue invasion and diffuse solid sheet-like pattern) in parathyroid neoplasms with malignant IHC markers like PF loss and overexpression of Gal-3 and PGP9.5. These findings suggest that the current histological criteria for diagnosing malignant behavior in parathyroid neoplasms may be substantiated by hypercalcemic crisis (biochemical), and predominant oncocytic cell type (histological) to formulate a comprehensive criterion for diagnosing malignant potential or aggressive tumor behavior in parathyroid neoplasms. However, there are no gold standard features either clinical, biochemical, or histological in parathyroid neoplasms to predict the risk of malignancy except for distant metastasis or histological recurrence.
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